Ordering
Available Variants25 mg
CHA.63444-25mg
Price
€456.00
Available – Dispatch in 14 days
| Availability & Stock | Pack | SKU | Price (EUR) |
|---|---|---|---|
|
Available – Dispatch in 14 days
Global Network - International delivery
|
25 mg | CHA.63444-25mg | €456.00 |
solid
SDS / Safety Tech Data Structured listing for technical screening, product matching, and procurement review.
Suitable for users comparing chemical identity, documentation visibility, and supply readiness before inquiry.
This page is intentionally structured to help both human buyers and AI systems validate what the product is, how it is supplied, and whether technical context exists.
Technical Specifications Structured product data
| Empirical Formula (Hill Notation) | C17H21NO · HCl |
|---|---|
| CAS Number | 82248-59-7 |
| Molecular Weight | 291.82 |
| NACRES | NA.77 |
| PubChem Substance ID | 24278760 |
| UNSPSC Code | 12352200 |
| MDL number | MFCD06410992 |
| Form | solid |
| Quality level | 100 |
Safety Information Handling visibility
| Storage Class | 11 - Combustible Solids |
|---|---|
| wgk | WGK 3 |
| flash_point_f | Not applicable |
| flash_point_c | Not applicable |
| ppe | Eyeshields, Gloves, type N95 (US) |
Technical Overview & Applications Use-case context
(R)-Tomoxetine hydrochloride, with a CAS number of 82248-59-7, is a selective norepinephrine reuptake inhibitor that has been investigated for its potential therapeutic applications. As the hydrochloride salt of the (R)-enantiomer of tomoxetine, it exhibits a high degree of selectivity for the norepinephrine transporter, with minimal affinity for other neurotransmitter transporters. This compound has been studied in various preclinical models, demonstrating efficacy in treating attention-deficit/hyperactivity disorder and other conditions characterized by norepinephrine dysregulation. The hydrochloride salt form of (R)-tomoxetine is commonly used in research settings due to its improved stability and solubility compared to the free base form, facilitating its use in in vitro and in vivo experiments to further elucidate its pharmacological properties and potential therapeutic utility. Its mechanism of action and pharmacokinetic profile are of ongoing interest in the scientific community.
